ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Consun Pharmaceutical Group Ltd. ?
1
High Management Efficiency with a high ROE of 21.94%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 42.92
3
Poor long term growth as Operating profit has grown by an annual rate 20.17% of over the last 5 years
4
The company has declared Positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at HKD 2,651.26 MM
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
- RAW MATERIAL COST(Y) Fallen by -6.98% (YoY)
5
With ROE of 23.09%, it has a Fair valuation with a 3.14 Price to Book Value
- Over the past year, while the stock has generated a return of 44.69%, its profits have risen by 21.1% ; the PEG ratio of the company is 0.8
6
Consistent Returns over the last 3 years
- Along with generating 44.69% returns in the last 1 year, the stock has outperformed Hang Seng Hong Kong in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Consun Pharmaceutical Group Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Consun Pharmaceutical Group Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Consun Pharmaceutical Group Ltd.
44.69%
3.34
37.05%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
15.43%
EBIT Growth (5y)
20.17%
EBIT to Interest (avg)
42.92
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.88
Sales to Capital Employed (avg)
0.66
Tax Ratio
10.07%
Dividend Payout Ratio
52.95%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
121.96%
ROE (avg)
21.94%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
3.14
EV to EBIT
9.43
EV to EBITDA
8.95
EV to Capital Employed
17.71
EV to Sales
3.07
PEG Ratio
0.82
Dividend Yield
NA
ROCE (Latest)
187.86%
ROE (Latest)
23.09%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 2,651.26 MM
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -6.98% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 2.67 times
DIVIDEND PER SHARE(HY)
Highest at HKD 9.4
NET SALES(Q)
Highest at HKD 2,023.96 MM
OPERATING PROFIT(Q)
Highest at HKD 733.81 MM
OPERATING PROFIT MARGIN(Q)
Highest at 36.26 %
PRE-TAX PROFIT(Q)
Highest at HKD 720.96 MM
NET PROFIT(Q)
Highest at HKD 631.34 MM
EPS(Q)
Highest at HKD 0.74
-1What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -81.09 %
Here's what is working for Consun Pharmaceutical Group Ltd.
Operating Cash Flow
Highest at HKD 2,651.26 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Net Sales
Highest at HKD 2,023.96 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Operating Profit
Highest at HKD 733.81 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (HKD MM)
Operating Profit Margin
Highest at 36.26 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at HKD 720.96 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
Highest at HKD 631.34 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
EPS
Highest at HKD 0.74
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Inventory Turnover Ratio
Highest at 2.67 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Dividend per share
Highest at HKD 9.4
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (HKD)
Raw Material Cost
Fallen by -6.98% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
At HKD 38.77 MM has Grown at 17.66%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Consun Pharmaceutical Group Ltd.
Debt-Equity Ratio
Highest at -81.09 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
